Revvity Signals 2024: Empowering Scientific Innovation and Collaboration
In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in drug discovery and research development.
Search Results
Revvity Ignites Scientific Breakthroughs at SLAS 2025
Revvity introduces groundbreaking Phenologic.AI software at SLAS 2025, transforming cellular imaging workflows and showcasing innovative life sciences solutions for drug discovery and development.
The Evolving Landscape of PROTAC® Technology: Implications for Small Molecule and Multimodal Drug Discovery
PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals One provides a comprehensive R&D workflow.
The Impact of Software Platforms on CRO and Biopharma Partnerships | Revvity Signals Software
Signals Synergy enhances collaboration and information between CROs and sponsors. Learn how Signals Synergy improves communication and project management with CROs.
